Out of stock

This item is currently unavailable

Gone for 334 days. Could come back at any time — we're watching for you.

Out of stock 334 days · last price £790

World Outlook for Diabetic Macular Edema 2025-2030 Study

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 400 days · 400 data points (no recent data)

Historical
Generating forecast…
£790.00 £750.50 £766.30 £782.10 £797.90 £813.70 £829.50 02 August 2025 09 November 2025 17 February 2026 28 May 2026 05 September 2026
View at Amazon ↗
Out of stock

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 400 days • 1 price levels

Days at Price
400 days 0 100 200 300 400 £790 Days at Price

Price Analysis

Most common price: £790 (400 days, 100.0%)

Price range: £790 - £790

Price levels: 1 different prices over 400 days

Description

This comprehensive market study provides a detailed world outlook for diabetic macular edema spanning the years 2025 through 2030. Covering more than 190 countries, the report offers essential data for understanding global market dynamics and economic trends within this sector. Using econometric models to project fundamental economic dynamics, the research provides estimates for latent demand, also known as potential industry earnings (P.I.E.), for each reported year. These figures are presented in millions of U.S. dollars for each specific country. To aid in comparative analysis, the report includes the percent share each country holds within its respective region and of the global market. These benchmarks enable readers to quickly assess a country's position relative to others on a global scale.

Key Features

Covers a global outlook for diabetic macular edema across more than 190 countries.

Provides latent demand estimates, or potential industry earnings (P.I.E.), in millions of U.S. dollars.

Includes regional and global percent share data to allow for quick comparative benchmarking between countries.

Utilizes econometric models to project fundamental economic dynamics within and across countries.

Delivers annual reports spanning the period from 2025 to 2030 for long-term planning.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
05 May 2024

Similar Products You Might Like

The 2026-2031 World Outlook for Diabetic Macular Edema
99% match

The 2026-2031 World Outlook for Diabetic Macular Edema

£885.00 02 Sep 2026
Anti-VEGF Diabetic Macular Edema Outlook 2023-2028 Report
97% match

Anti-VEGF Diabetic Macular Edema Outlook 2023-2028 Report

£490.00 28 Oct 2026
US Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028
97% match

US Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028

£520.00 26 Aug 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
97% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 02 Nov 2026
US Macular Degeneration Treatment Outlook 2023-2028 Study
97% match

US Macular Degeneration Treatment Outlook 2023-2028 Study

£520.00 26 Aug 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
97% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 29 Oct 2026
Macular Degeneration Treatment Outlook in India 2023-2028
97% match

Macular Degeneration Treatment Outlook in India 2023-2028

£515.00 26 Aug 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in Japan
97% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in Japan

£495.00 30 Oct 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan
97% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in Japan

£495.00 04 Nov 2026
World Outlook for Smart Diabetes Management 2025-2030
97% match

World Outlook for Smart Diabetes Management 2025-2030

Price unavailable
The 2023-2028 Outlook for Macular Degeneration Treatments in Japan
97% match

The 2023-2028 Outlook for Macular Degeneration Treatments in Japan

£495.00 28 Oct 2026
Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028
97% match

Proliferative Diabetic Retinopathy Treatment Outlook 2023-2028

£490.00 26 Aug 2026
The 2023-2028 World Outlook for Diabetes Monitoring, Treatment, and Drug Delivery Products
96% match

The 2023-2028 World Outlook for Diabetes Monitoring, Treatment, and Drug Delivery Products

Price unavailable
The 2021-2026 World Outlook for Intraocular Pressure Monitoring Devices
96% match

The 2021-2026 World Outlook for Intraocular Pressure Monitoring Devices

Price unavailable
World Outlook: Next Gen Diabetes Therapy 2025-2030 Study
96% match

World Outlook: Next Gen Diabetes Therapy 2025-2030 Study

Price unavailable
The 2021-2026 World Outlook for Ophthalmic Diagnostic Equipment
96% match

The 2021-2026 World Outlook for Ophthalmic Diagnostic Equipment

£795.00 29 Oct 2026
World Outlook for Online Sales of Diabetic Shoes 2025-2030
96% match

World Outlook for Online Sales of Diabetic Shoes 2025-2030

Price unavailable
World Outlook for Dry Eye Syndrome Treatments 2025-2030
96% match

World Outlook for Dry Eye Syndrome Treatments 2025-2030

Price unavailable
World Outlook for Diabetic Socks 2025-2030 Market Study
96% match

World Outlook for Diabetic Socks 2025-2030 Market Study

Price unavailable
The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States
96% match

The 2023-2028 Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema in the United States

£520.00 03 Oct 2026
Uveitis Drugs in India Market Outlook 2023-2028 Report
96% match

Uveitis Drugs in India Market Outlook 2023-2028 Report

£515.00 28 Aug 2026
Macular Degeneration Treatment Outlook 2023-2028 Study
96% match

Macular Degeneration Treatment Outlook 2023-2028 Study

£490.00 07 Nov 2026
The 2021-2026 World Outlook for Uveitis Treatments
96% match

The 2021-2026 World Outlook for Uveitis Treatments

Price unavailable
India Eye Drops Market Outlook 2023-2028 Study Report
96% match

India Eye Drops Market Outlook 2023-2028 Study Report

£515.00 26 Aug 2026